The changing landscape of phase I trials in oncology | Nature Reviews Clinical Oncology
Volume 18 | Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology - erikoislääkärikuulustelu Nat Rev Clin Oncol - Terkko Navigator
Drug repurposing in oncology—patient and health systems opportunities | Nature Reviews Clinical Oncology
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? | Nature Reviews Clinical Oncology
Volume 14 | Nature Reviews Clinical Oncology
Volume 16 | Nature Reviews Clinical Oncology
Volume 13 | Nature Reviews Clinical Oncology
Article Series: Nature Reviews Clinical Oncology
Volume 18 Issue 6, June 2021
Tumour heterogeneity and resistance to cancer therapies | Nature Reviews Clinical Oncology
Volume 19 | Nature Reviews Clinical Oncology
Volume 8 | Nature Reviews Clinical Oncology
Work featured in Nature Reviews Clinical Oncology | Gevaert Lab | Stanford Medicine
Volume 19 Issue 5, May 2022
Volume 16 | Nature Reviews Clinical Oncology
Progress in refining the clinical management of cancer of unknown primary in the molecular era | Nature Reviews Clinical Oncology
Collections | Nature Reviews Clinical Oncology
Driving CAR T-cells forward | Nature Reviews Clinical Oncology
Volume 15 | Nature Reviews Clinical Oncology
Computational oncology — mathematical modelling of drug regimens for precision medicine | Nature Reviews Clinical Oncology
Imaging biomarker roadmap for cancer studies | Nature Reviews Clinical Oncology
